BPC-157 + TB-500
The two most-studied tissue-repair research peptides co-formulated in a single 20 mg vial.
Research Overview
This blend pairs the two compounds most frequently used together in tissue-repair research. BPC-157, a pentadecapeptide derived from a gastric protein sequence, is studied for VEGF-pathway signaling, fibroblast migration and angiogenesis in injury models.
TB-500 is the synthetic fragment corresponding to the actin-binding domain of thymosin β4, investigated for actin sequestration and its effects on cell motility and migration.
Specifications
| Compound | BPC-157 + TB-500 |
| Classification | Regenerative research compound |
| Constituents | BPC-157 10 mg — 1,419.5 g/mol TB-500 10 mg — 4,963.4 g/mol |
| Molecular weight | Blend — see constituents |
| Sequence / Form | BPC-157 10 mg · TB-500 10 mg |
| Purity | ≥98% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
